Home Pill Identifier ULTRASE MT 18

ULTRASE MT 18

Generic Name: pancrelipase

Pill imprint ULTRASE MT 18 has been identified as Ultrase MT 18 58,500 units amylase; 18,000 units lipase; 58,500 units protease.

Ultrase MT 18 is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy.

Ultrase MT 18 58,500 units amylase; 18,000 units lipase; 58,500 units protease is not subject to the Controlled Substances Act.
See also related documents.

Ultrase MT 18 Images

Generic Name:
pancrelipase
Imprint:
ULTRASE
MT 18
Strength:
58,500 units amylase; 18,000 units lipase; 58,500 units protease
Color:
Gray / White
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Axcan Scandipharm Inc.
National Drug Code (NDC):
58914-0018

View Drug DetailsPrint Page

Ultrase MT 18 58,500 units amylase; 18,000 units lipase; 58,500 units protease ULTRASE MT 18
Advertisement

Ultrase MT 18 is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web4)